542 filings
Page 4 of 28
UPLOAD
qs5hzn
22 Sep 21
Letter from SEC
12:00am
8-K
087zlab0pl2dtx8u
3 Aug 21
Neurocrine Biosciences Reports Second Quarter 2021 Financial Results
4:02pm
8-K
9s0i9c xmcuua
21 May 21
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
0r3vrpewf3ocj0r xn
5 May 21
Neurocrine Biosciences Reports First Quarter 2021 Financial Results
4:05pm
8-K
w2g i011xu
16 Apr 21
Departure of Directors or Certain Officers
9:02am
DEFA14A
5hvmngpriqbg yl
9 Apr 21
Additional proxy soliciting materials
5:09pm
8-K
6rnzv3m
4 Feb 21
Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results
4:05pm
8-K
yuol bs7fb
2 Feb 21
Other Events
4:04pm
8-K
03y m0udbooslwozs14v
8 Jan 21
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones
7:32am
8-K
0k5hwdpzg1t
24 Nov 20
Other Events
8:02am
8-K
2nmrh
19 Nov 20
Neurocrine Biosciences Announces Repurchase of Convertible Notes
8:07am
8-K
2tri54dgb 0bz
9 Nov 20
Neurocrine Biosciences Reports Third Quarter 2020 Financial Results
4:02pm
8-K
q14kd57j3wpnxmbe37
10 Sep 20
Neurocrine Biosciences at Citi 15th Annual Biopharma Virtual Conference
8:30am
8-K
1tqxe 0bmq
28 Aug 20
Amendments to Articles of Incorporation or Bylaws
4:03pm
S-8 POS
xv6 40ntei
3 Aug 20
Registration of securities for employees (post-effective amendment)
4:45pm